Article
Brochure
Executive Resource
Video
Ext. Publication
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- ESG Strategy & Consulting
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Transaction Advisory
- Trust & Estate
- Valuation
New York’s business interruption law introduced new stand-alone coverage opportunities, providing businesses options for tailored protection.
PodcastT.J. Liles-Tims and Liza Bowersox discuss the intricacies of business valuation and strategies for reducing conflicts.
Weaver's Conversations on Fraud series explores the importance for organizations to establish controls and the segregation of duties to prevent fraud.
Our Conversations on Fraud series explores the impact of artificial intelligence in forensic accounting investigations during Fraud Awareness Week.
Weaver's Conversations on Fraud series explores ABAC regulations, including DOJ/SEC compliance expectations, data analytics and enforcement programs.
During Fraud Awareness Week, Weaver's Conversations on Fraud series explores stock loan fraud schemes and how public companies can protect themselves.
Insight HubWeaver professionals will support the efforts by ACFE to minimize the impact of fraud by promoting anti-fraud awareness and education during International Fraud Awareness Week.
The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.
The biopharma industry has experienced a resurgence the first part of 2024. J.P. Morgan’s Q2 report shares critical insights into the future of the industry.
Ardent Health’s recent IPO highlights the company’s unique qualities, though it creates valuation comparability challenges for joint ventures and leased facilities.
The instances of urgent care clinic visits have returned to pre-pandemic levels, but COVID-related services still make up a large percentage of the total volume.
Featured in American Health Law Association’s online publication, Weaver partners Corey Palasota and Tashiana Briggs outline personal goodwill in health care M&A transactions.